2021 AUSA Annual Meeting Entry Requirements

AUSA Annual Meeting Update — New COVID Requirements Updated as of 14 SEPT 21

We are looking forward to seeing you at the in-person 2021 AUSA Annual Meeting in October and are taking steps to make certain this year’s event is safe and healthy in the face of rising Delta variant COVID-19 cases.  To do this, we have new guidance for the meeting. Proof of full vaccination will be required to attend the in-person event at the Walter E. Washington Convention Center in Washington, D.C.  

Prior to the Annual Meeting, attendees will be asked to upload proof that full vaccination was completed at least 14 days prior to arriving in Washington, D.C.  

For entry to the AUSA Annual Meeting, a person is considered fully vaccinated:

•    14 days after their second dose of a two-dose vaccine series, such as the Pfizer and Moderna vaccines or any World Health Organization-approved vaccine for international participants listed below.
  • Oxford/AstraZeneca
  • Serum Institute of India/Covishield 
  • Sinopharm (Beijing) 
  • Sinovac/CoronaVac
•    14 days after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine.

There will be no exceptions to the requirement to be fully vaccinated.